Results 41 to 50 of about 6,839 (215)
Kidney International Reports, 2019 Introduction: Transplant glomerulopathy (TG) becomes increasingly prevalent in kidney transplant recipients over time, and it is strongly associated with allograft failure.
Sarah E. Panzer +5 more
doaj +1 more source
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report. [PDF]
, 2009 INTRODUCTION: Lipoprotein glomerulopathy is a glomerulonephritis which was described for the first time by Saito in 1989 and is currently acknowledged as a separate nosological entity.
ALBERTAZZI, Alberto +6 more
core +2 more sources
Recent insights into C3 glomerulopathy [PDF]
Nephrology Dialysis Transplantation, 2013 'C3 glomerulopathy' is a recent disease classification comprising several rare types of glomerulonephritis (GN), including dense deposit disease (DDD), C3 glomerulonephritis (C3GN) and CFHR5 nephropathy. These disorders share the key histological feature of isolated complement C3 deposits in the glomerulus. A common aetiology involving dysregulation of
Barbour, TD, Pickering, MC, Cook, HT
openaire +4 more sources
Histomorphological and clinical study of primary and secondary glomerulopathies in Southeast Serbia (20-year period of analysis) [PDF]
, 2013 Background/Aim. Epidemiological studies of renal biopsies have been performed to follow up the incidence of glomerular diseases on a specified territory and to compare the obtained results with results from other regions.
Savić Vojin +2 more
core +1 more source
C3 glomerulopathy in cystic fibrosis: a case report
BMC Nephrology, 2018 Background C3 glomerulonephritis is a rare glomerulopathy characterized at renal biopsy by C3 deposition, alone or with scanty immunoglobulins, as well as by an electron-dense material in mesangium, subendothelial and subepithelial space.
Domenico Santoro +9 more
doaj +1 more source
C3 glomerulopathy and current dilemmas [PDF]
Clinical and Experimental Nephrology, 2016 C3 glomerulopathy (C3G) is a recently identified disease entity caused by dysregulation of the alternative complement pathway, and dense deposit disease (DDD) and C3 glomerulonephritis (C3GN) are its components. Because laboratory detection of complement dysregulation is still uncommon in practice, "dominant C3 deposition by two orders greater than ...
Naoko Ito, Ryuji Ohashi, Michio Nagata
openaire +2 more sources
Anti-glomerular basement membrane disease superimposed on membranous nephropathy: a case report and review of the literature [PDF]
, 2010 Introduction Anti-glomerular basement membrane disease is a rare autoimmune disorder characterized by pulmonary hemorrhage, crescentic glomerulonephritis and the presence of circulating anti-glomerular basement membrane antibodies.
Dhruval Patel +2 more
core +1 more source
, 2018 <p>C3 glomerulopathy (C3G) encompasses a group of severe renal diseases characterized by “dominant C3” deposition in the renal glomerulus. Patients typically present as nephritic nephrotics, with hematuria, hypertension, heavy proteinuria and edema.
Xue Xiao +5 more
openaire +4 more sources
Transplacental induction of membranous nephropathy in a neonate [PDF]
, 1990 We report a case of renal failure in a newborn infant due to membranous glomerulonephritis. The patient was anuric in the first 3 weeks of life, after which renal function recovered.
Baldwin III, W.M. (William) +5 more
core +1 more source
Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome. [PDF]
, 2014 The alternative pathway of complement is implicated in the pathogenesis of several renal diseases, such as atypical hemolytic uremic syndrome, dense deposit disease and other forms of C3 glomerulopathy.
Józsi, Mihály +6 more
core +1 more source